Funding to identify and implement molecular testing for those affected by a brain tumour.
This scheme supports the identification, validation, and implementation of clinical biomarkers into clinical use and bring us closer to an early and accurate diagnosis. Studies may make use of the samples and infrastructure brought about by funded clinical trials, to go beyond the primary and secondary endpoints and generate new knowledge around clinical biomarkers.
Guide costs: up to £100,000 per year for up to five years.
Funding is intended to allow the production of new insights (e.g. identification of new biomarkers or further stratification of the trial population) which will lead us to early and accurate diagnosis. This funding should be primarily allocated to cover direct costs of consumables, and additional Full-Time Equivalent costs where appropriate justification is made. Requests for capital /infrastructure will not be considered since it is expected that this will be available at the Lead Institution as well as all partner organisations.
Grants will be awarded to the principal applicant's institution. Funding can be allocated to co-investigator institutions with agreements put in place between all partner institutions.
All applications must have input from those affected by brain tumours as early as possible, preferably during scoping of the project. We strongly recommend that applicants access our Research Involvement Network (RIN) for public and patient involvement. In order to receive feedback from the RIN, please allow for a minimum of 3 weeks turnaround time.
Monday 16 July, 2018: Application Open
Monday 3 September, 2018 17:00 (BST): Deadline for receipt of full applications
Applications will be reviewed by our Scientific Advisory Board in February 2019.
Interested applicants should complete the application form provided below.
Expertise of applicants
Potential for patient benefit
Value for money
The Brain Tumour Charity is a member of the Association of Medical Research Charities (AMRC) and adheres to its principles of peer review. Applications will be awarded through a competitive peer reviewed process (in line with AMRC principles) and then considered by our Scientific Advisory Boards (SABs).
If you would like to discuss project ideas or need any information, please contact the Research Team.
Phone: +44 (0) 1252 418190